Hydroxyurea for the prevention of stroke and other vasoocclusive complications in children with sickle cell disease.

被引：0
|
作者：
Schmugge, M
Zurbriggen, K
Albisetti, M
Schmid, M
Baumgartner, RW
Sztajzel, R
Martin, G
Ozsahin, H
机构：
[1] Univ Childrens Hosp, Zurich, Switzerland
[2] Univ Hosp, Zurich, Switzerland
[3] Univ Hosp, Geneva, Switzerland
[4] Univ Childrens Hosp, Geneva, Switzerland
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3792
引用
收藏
页码：27B / 27B
页数：1
相关论文
共 50 条
  • [41] Hydroxyurea affects T-lymphocyte subsets in sickle cell disease.
    Sivasubramaniam, D
    Bekoe, O
    Motwani, B
    Allen, S
    Feldman, L
    Beaman, K
    Gilman-Sachs, A
    Feldman, LE
    [J]. BLOOD, 2004, 104 (11) : 17B - 18B
  • [42] Hydroxyurea for secondary stroke prevention in children with sickle cell anaemia: a systematic review of clinical evidence and outcomes
    Aderinto, Nicholas
    Olatunji, Gbolahan
    Kokori, Emmanuel
    Abdulbasit, Muili
    [J]. ANNALS OF MEDICINE AND SURGERY, 2024, 86 (02): : 1042 - 1047
  • [43] Hydroxyurea reverses increased adhesive properties of neutrophils in sickle cell disease.
    Canalli, Andreia A.
    Conran, Nicola
    Saad, Sara T. O.
    Costa, Fernando F.
    [J]. BLOOD, 2006, 108 (11) : 362A - 362A
  • [44] Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease.
    Gladwin, MT
    Shelhamer, JH
    Ognibene, FP
    Pannell, LK
    Schechter, AN
    Rodgers, GP
    [J]. BLOOD, 2000, 96 (11) : 485A - 485A
  • [45] Early predictors of fetal hemoglobin response to hydroxyurea in sickle cell disease.
    Partovi, K
    Martyr, S
    McGowan, V
    Machado, R
    Taylor, J
    Kato, G
    Gladwin, M
    Little, J
    [J]. BLOOD, 2005, 106 (11) : 659A - 660A
  • [46] Anti-inflammatory effect of hydroxyurea therapy in sickle cell disease.
    Lanaro, Carolina
    Franco-Penteado, Carla F.
    Conran, Nicola
    Saad, Sara T. O.
    Costa, Fernando F.
    [J]. BLOOD, 2006, 108 (11) : 27B - 27B
  • [47] Prevention of stroke recurrence with blood transfusions followed by hydroxyurea (HU) in patients with sickle cell disease (SCD)
    Aygun, B
    Moore, JW
    Karayalcin, G
    [J]. BLOOD, 2002, 100 (11) : 28B - 28B
  • [48] Prevention of stroke recurrence with blood transfusions followed by hydroxyurea (HU) in patients with sickle cell disease (SCD)
    Aygun, B
    Moore, JW
    Karayalcin, G
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 293A - 294A
  • [49] Inflammatory markers in acute complications of sickle cell disease.
    Dougaparsad, S
    Hardy-Dessources, MD
    Decastel, M
    Coezy, E
    Bourhis, V
    Le Turdu-Chicot, C
    Lebourgne, Y
    Saint Martin, L
    Bangou-Bredent, J
    Berchel, C
    [J]. BLOOD, 1998, 92 (10) : 28B - 28B
  • [50] Hydroxyurea to Reduce Stroke Risk in Tanzanian Children with Sickle Cell Anemia
    Ambrose, Emmanuela E.
    Smart, Luke R.
    Songoro, Primrose
    Shabani, Idd
    Komba, Protas
    Charles, Mwesige
    Howard, Thad A.
    Stuber, Susan E.
    Lane, Adam
    Latham, Teresa
    Makubi, Abel Nkono
    Ware, Russell E.
    [J]. BLOOD, 2020, 136
12345